Reina Adelys M, Mewa Juan Castillo, Calzada José E, Saldaña Azael
Departamento de Investigación en Parasitología, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panama 0816, Panama.
Departamento de Investigación en Genómica y Proteómica, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panama 0816, Panama.
Trop Med Infect Dis. 2022 Oct 3;7(10):282. doi: 10.3390/tropicalmed7100282.
A total of 123 DNA samples from Panamanian patients with cutaneous leishmaniasis (CL) lesions were evaluated. These samples were previously confirmed with CL by a specific KDNA-Viannia PCR but had a negative parasitological diagnosis (Group A). Epidemiological variables, such as age, sex, geographic origin, evolution time, and the number and location of the lesions, were analyzed. No significant differences (p < 0.05) were found when these variables were evaluated against a control panel of 123 CL lesion samples from CL patients with positive parasitological diagnoses (Group B). Of the 123 samples (Group A), 67% (82/123) gave positive results when re-analyzed by PCR-hsp70. An analysis of 69 of these samples via PCR-hsp70-RFLP showed that 59.4% (41/69) of the found restriction patterns corresponded to Leishmania (Viannia) panamensis and 40.6% (28/69) to Leishmania (Viannia) guyanensis. Finally, the sequence and phylogenetic analysis of 32 of the samples confirmed the species in 21 (65.6%, 21/32) samples, originally characterized as L. (V.) panamensis. However, 11 samples (34.4%, 11/32), initially identified via RFLP-Hsp70 as L. (V.) guyanensis, matched the sequence of a genetic variant known as Leishmania sp.1. These results point out the species/genetic variants of Leishmania in the case of CL lesions with an apparently low parasite load.
对来自巴拿马皮肤利什曼病(CL)患者病变部位的123份DNA样本进行了评估。这些样本先前通过特异性KDNA - Viannia PCR确诊为CL,但寄生虫学诊断为阴性(A组)。分析了年龄、性别、地理来源、病程以及病变数量和位置等流行病学变量。将这些变量与123份寄生虫学诊断阳性的CL患者病变样本组成的对照组(B组)进行评估时,未发现显著差异(p < 0.05)。在123份样本(A组)中,67%(82/123)经PCR - hsp70重新分析后呈阳性结果。通过PCR - hsp70 - RFLP对其中69份样本进行分析,结果显示所发现的限制性酶切图谱中,59.4%(41/69)对应巴拿马利什曼原虫(维阿尼亚种),40.6%(28/69)对应圭亚那利什曼原虫(维阿尼亚种)。最后,对32份样本进行序列和系统发育分析,在最初鉴定为巴拿马利什曼原虫(维阿尼亚种)的21份样本(65.6%,21/32)中确认了物种。然而,最初通过RFLP - Hsp70鉴定为圭亚那利什曼原虫(维阿尼亚种)的11份样本(34.4%,11/32),其序列与一种名为利什曼原虫sp.1的基因变体相匹配。这些结果指出了寄生虫负荷明显较低的CL病变病例中利什曼原虫的物种/基因变体。